Biofil Total Current Liabilities vs Retained Earnings Analysis

BIOFILCHEM   62.81  0.04  0.06%   
Biofil Chemicals financial indicator trend analysis is way more than just evaluating Biofil Chemicals Pha prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Biofil Chemicals Pha is a good investment. Please check the relationship between Biofil Chemicals Total Current Liabilities and its Retained Earnings accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Biofil Chemicals Pharmaceuticals. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product.

Total Current Liabilities vs Retained Earnings

Total Current Liabilities vs Retained Earnings Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Biofil Chemicals Pha Total Current Liabilities account and Retained Earnings. At this time, the significance of the direction appears to have weak relationship.
The correlation between Biofil Chemicals' Total Current Liabilities and Retained Earnings is 0.35. Overlapping area represents the amount of variation of Total Current Liabilities that can explain the historical movement of Retained Earnings in the same time period over historical financial statements of Biofil Chemicals Pharmaceuticals, assuming nothing else is changed. The correlation between historical values of Biofil Chemicals' Total Current Liabilities and Retained Earnings is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Total Current Liabilities of Biofil Chemicals Pharmaceuticals are associated (or correlated) with its Retained Earnings. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Retained Earnings has no effect on the direction of Total Current Liabilities i.e., Biofil Chemicals' Total Current Liabilities and Retained Earnings go up and down completely randomly.

Correlation Coefficient

0.35
Relationship DirectionPositive 
Relationship StrengthVery Weak

Total Current Liabilities

Total Current Liabilities is an item on Biofil Chemicals balance sheet that include short term debt, accounts payable, accrued salaries payable, payroll taxes payable, accrued liabilities and other debts. Total Current Liabilities of Biofil Chemicals Pharmaceuticals are important to investors because some useful performance ratios such as Current Ratio and Quick Ratio require Total Current Liabilities to be accurate. The total amount of liabilities that a company is expected to pay within one year, including debts, accounts payable, and other short-term financial obligations.

Retained Earnings

The cumulative amount of net income that a company retains for reinvestment in its operations, rather than distributing it to shareholders as dividends.
Most indicators from Biofil Chemicals' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Biofil Chemicals Pha current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Biofil Chemicals Pharmaceuticals. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product.
The current year's Selling General Administrative is expected to grow to about 7 M. The current year's Tax Provision is expected to grow to about 2.4 M
 2021 2022 2023 2024 (projected)
Gross Profit29.2M21.4M25.3M21.7M
Total Revenue223.8M300.4M400.4M420.4M

Biofil Chemicals fundamental ratios Correlations

-0.40.71-0.17-0.32-0.63-0.770.6-0.29-0.26-0.17-0.650.04-0.17-0.350.98-0.24-0.140.39-0.19-0.35-0.930.040.27-0.25-0.34
-0.4-0.730.360.820.810.37-0.750.540.830.470.35-0.270.470.86-0.330.670.42-0.450.80.860.57-0.37-0.720.690.83
0.71-0.73-0.18-0.61-0.93-0.640.93-0.64-0.61-0.44-0.590.02-0.44-0.730.61-0.66-0.110.68-0.54-0.74-0.760.090.87-0.73-0.85
-0.170.36-0.180.310.270.59-0.120.010.3-0.040.65-0.65-0.040.31-0.210.10.68-0.450.290.280.13-0.89-0.110.350.23
-0.320.82-0.610.310.520.39-0.770.351.00.760.41-0.240.760.97-0.230.660.35-0.240.990.970.53-0.3-0.60.650.59
-0.630.81-0.930.270.520.55-0.830.70.540.310.5-0.160.310.67-0.540.630.21-0.70.460.680.69-0.19-0.840.750.94
-0.770.37-0.640.590.390.55-0.520.190.350.10.99-0.450.10.41-0.750.420.46-0.650.290.410.64-0.53-0.320.450.35
0.6-0.750.93-0.12-0.77-0.83-0.52-0.54-0.77-0.74-0.480.01-0.74-0.850.48-0.72-0.030.46-0.71-0.87-0.770.030.84-0.77-0.83
-0.290.54-0.640.010.350.70.19-0.540.370.140.16-0.10.150.51-0.190.39-0.02-0.420.330.510.320.01-0.710.650.71
-0.260.83-0.610.31.00.540.35-0.770.370.760.38-0.230.770.98-0.160.680.33-0.261.00.980.47-0.3-0.650.680.62
-0.170.47-0.44-0.040.760.310.1-0.740.140.760.110.031.00.74-0.040.54-0.140.120.770.770.480.11-0.470.540.45
-0.650.35-0.590.650.410.50.99-0.480.160.380.11-0.520.110.42-0.630.460.51-0.670.330.430.53-0.61-0.330.490.34
0.04-0.270.02-0.65-0.24-0.16-0.450.01-0.1-0.230.03-0.520.03-0.20.04-0.28-0.690.21-0.24-0.2-0.030.790.01-0.46-0.18
-0.170.47-0.44-0.040.760.310.1-0.740.150.771.00.110.030.74-0.040.55-0.140.120.770.770.480.11-0.480.540.45
-0.350.86-0.730.310.970.670.41-0.850.510.980.740.42-0.20.74-0.240.690.31-0.380.961.00.55-0.25-0.760.760.74
0.98-0.330.61-0.21-0.23-0.54-0.750.48-0.19-0.16-0.04-0.630.04-0.04-0.24-0.12-0.20.37-0.09-0.23-0.880.070.14-0.11-0.23
-0.240.67-0.660.10.660.630.42-0.720.390.680.540.46-0.280.550.69-0.120.08-0.430.650.740.37-0.29-0.720.770.72
-0.140.42-0.110.680.350.210.46-0.03-0.020.33-0.140.51-0.69-0.140.31-0.20.08-0.460.330.270.06-0.7-0.050.170.17
0.39-0.450.68-0.45-0.24-0.7-0.650.46-0.42-0.260.12-0.670.210.12-0.380.37-0.43-0.46-0.2-0.37-0.250.410.65-0.46-0.62
-0.190.8-0.540.290.990.460.29-0.710.331.00.770.33-0.240.770.96-0.090.650.33-0.20.960.41-0.3-0.60.650.57
-0.350.86-0.740.280.970.680.41-0.870.510.980.770.43-0.20.771.0-0.230.740.27-0.370.960.55-0.24-0.770.780.76
-0.930.57-0.760.130.530.690.64-0.770.320.470.480.53-0.030.480.55-0.880.370.06-0.250.410.550.0-0.390.40.49
0.04-0.370.09-0.89-0.3-0.19-0.530.030.01-0.30.11-0.610.790.11-0.250.07-0.29-0.70.41-0.3-0.240.00.09-0.37-0.2
0.27-0.720.87-0.11-0.6-0.84-0.320.84-0.71-0.65-0.47-0.330.01-0.48-0.760.14-0.72-0.050.65-0.6-0.77-0.390.09-0.83-0.93
-0.250.69-0.730.350.650.750.45-0.770.650.680.540.49-0.460.540.76-0.110.770.17-0.460.650.780.4-0.37-0.830.85
-0.340.83-0.850.230.590.940.35-0.830.710.620.450.34-0.180.450.74-0.230.720.17-0.620.570.760.49-0.2-0.930.85
Click cells to compare fundamentals

Biofil Chemicals Account Relationship Matchups

Biofil Chemicals fundamental ratios Accounts

201920202021202220232024 (projected)
Total Assets423.6M332.4M187.3M314.1M470.8M242.1M
Short Long Term Debt Total11.9M4.3M4.6M5.2M4.4M4.2M
Other Current Liab15.6M1.4M1.6M933K2.9M3.9M
Total Current Liabilities274.8M167.5M14.9M137.3M285.2M299.5M
Total Stockholder Equity148.8M161.3M168.4M173.0M182.0M119.5M
Property Plant And Equipment Net100.9M97.8M94.2M90.0M86.2M99.3M
Net Debt9.4M(107K)3.2M5.0M(18.4M)(17.5M)
Retained Earnings(350.1M)(337.7M)(330.6M)(128.5M)(316.9M)(332.8M)
Accounts Payable259.2M158.5M6.0M126.5M275.5M289.3M
Cash2.6M4.4M1.5M260K22.8M24.0M
Non Current Assets Total100.9M97.8M94.2M90.0M86.8M99.9M
Non Currrent Assets Other(100.9M)(37K)(191K)(307K)508K533.4K
Cash And Short Term Investments2.6M4.4M1.5M377K22.8M24.0M
Net Receivables299.2M186.0M71.8M205.0M330.3M346.8M
Liabilities And Stockholders Equity423.6M332.4M187.3M314.1M470.8M242.1M
Inventory16.9M43.4M12.9M12.1M25.5M26.8M
Other Current Assets303.2M793K7.0M6.5M5.5M5.2M
Total Liab274.8M171.1M18.9M141.0M288.8M303.2M
Total Current Assets322.7M234.6M93.1M224.1M384.1M403.3M
Current Deferred Revenue(11.9M)(4.3M)4.3M2.3M1.4M1.5M
Short Term Debt11.9M4.3M4.6M2.9M4.4M4.2M
Net Tangible Assets136.5M148.8M161.3M168.4M193.6M140.0M
Short Long Term Debt11.9M4.3M4.6M5.2M4.4M4.2M
Property Plant Equipment100.9M97.8M94.2M90.0M103.5M103.6M
Net Invested Capital160.8M165.6M173.0M178.2M186.4M182.9M
Cash And Equivalents2.6M4.4M1.4M260K234K222.3K
Net Working Capital47.9M67.1M78.2M86.8M98.8M71.0M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Other Information on Investing in Biofil Stock

Balance Sheet is a snapshot of the financial position of Biofil Chemicals Pha at a specified time, usually calculated after every quarter, six months, or one year. Biofil Chemicals Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of Biofil Chemicals and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which Biofil currently owns. An asset can also be divided into two categories, current and non-current.